Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.

Smith AK, Fang H, Whistler T, Unger ER, Rajeevan MS.

Neuropsychobiology. 2011;64(4):183-94. doi: 10.1159/000326692. Epub 2011 Sep 9.

2.

Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.

Schlauch KA, Khaiboullina SF, De Meirleir KL, Rawat S, Petereit J, Rizvanov AA, Blatt N, Mijatovic T, Kulick D, Palotás A, Lombardi VC.

Transl Psychiatry. 2016 Feb 9;6:e730. doi: 10.1038/tp.2015.208.

3.

Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Shimosako N, Kerr JR.

J Clin Pathol. 2014 Dec;67(12):1078-83. doi: 10.1136/jclinpath-2014-202597. Epub 2014 Sep 19.

PMID:
25240059
5.

Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder.

Soria V, Martínez-Amorós E, Escaramís G, Valero J, Pérez-Egea R, García C, Gutiérrez-Zotes A, Puigdemont D, Bayés M, Crespo JM, Martorell L, Vilella E, Labad A, Vallejo J, Pérez V, Menchón JM, Estivill X, Gratacòs M, Urretavizcaya M.

Neuropsychopharmacology. 2010 May;35(6):1279-89. doi: 10.1038/npp.2009.230. Epub 2010 Jan 13.

6.

A functional polymorphism in the disrupted-in schizophrenia 1 gene is associated with chronic fatigue syndrome.

Fukuda S, Hashimoto R, Ohi K, Yamaguti K, Nakatomi Y, Yasuda Y, Kamino K, Takeda M, Tajima S, Kuratsune H, Nishizawa Y, Watanabe Y.

Life Sci. 2010 May 8;86(19-20):722-5. doi: 10.1016/j.lfs.2010.03.007. Epub 2010 Mar 20.

PMID:
20227423
7.

Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.

Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C, Reeves WC.

Genes Brain Behav. 2007 Mar;6(2):167-76.

8.

A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.

Wang F, Hu Z, Yang R, Tang J, Liu Y, Hemminki K, Sutter C, Wappenschmidt B, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Burwinkel B, Shen H.

Breast Cancer Res Treat. 2011 Jun;127(3):769-75. doi: 10.1007/s10549-010-1157-8. Epub 2010 Dec 8.

PMID:
21140207
9.

Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome.

Rajeevan MS, Dimulescu I, Murray J, Falkenberg VR, Unger ER.

Hum Immunol. 2015 Aug;76(8):553-60. doi: 10.1016/j.humimm.2015.06.014. Epub 2015 Jun 24.

10.

Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.

Rana S, Shahid A, Ullah H, Mahmood S.

Asian Pac J Cancer Prev. 2014;15(17):7169-74.

11.

Common genetic variants in ARNTL and NPAS2 and at chromosome 12p13 are associated with objectively measured sleep traits in the elderly.

Evans DS, Parimi N, Nievergelt CM, Blackwell T, Redline S, Ancoli-Israel S, Orwoll ES, Cummings SR, Stone KL, Tranah GJ; Study of Osteoporotic Fractures (SOF); Osteoporotic Fractures in Men (MrOS) Study Group.

Sleep. 2013 Mar 1;36(3):431-46. doi: 10.5665/sleep.2466.

12.

A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma.

Franzoni A, Markova-Car E, Dević-Pavlić S, Jurišić D, Puppin C, Mio C, De Luca M, Petruz G, Damante G, Pavelić SK.

Exp Biol Med (Maywood). 2017 Sep;242(15):1553-1558. doi: 10.1177/1535370217724093. Epub 2017 Aug 11.

PMID:
28799406
13.

Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.

Marshall-Gradisnik S, Johnston S, Chacko A, Nguyen T, Smith P, Staines D.

J Int Med Res. 2016 Dec;44(6):1381-1394. doi: 10.1177/0300060516671622. Epub 2016 Nov 11.

14.

Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome.

Gräns H, Nilsson M, Dahlman-Wright K, Evengård B.

J Clin Pathol. 2007 Feb;60(2):195-8. Epub 2006 May 26.

15.

Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome.

Vernon SD, Unger ER, Dimulescu IM, Rajeevan M, Reeves WC.

Dis Markers. 2002;18(4):193-9.

16.

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.

Yi C, Mu L, de la Longrais IA, Sochirca O, Arisio R, Yu H, Hoffman AE, Zhu Y, Katsaro D.

Breast Cancer Res Treat. 2010 Apr;120(3):663-9. doi: 10.1007/s10549-009-0484-0. Epub 2009 Aug 1.

17.

Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.

Yi CH, Zheng T, Leaderer D, Hoffman A, Zhu Y.

Cancer Lett. 2009 Nov 1;284(2):149-56. doi: 10.1016/j.canlet.2009.04.017. Epub 2009 May 19.

18.

Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.

Light AR, White AT, Hughen RW, Light KC.

J Pain. 2009 Oct;10(10):1099-112. doi: 10.1016/j.jpain.2009.06.003. Epub 2009 Jul 31.

19.

Genetic association study of circadian genes with seasonal pattern in bipolar disorders.

Geoffroy PA, Lajnef M, Bellivier F, Jamain S, Gard S, Kahn JP, Henry C, Leboyer M, Etain B.

Sci Rep. 2015 May 19;5:10232. doi: 10.1038/srep10232.

20.

Genetic evaluation of the serotonergic system in chronic fatigue syndrome.

Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, Rajeevan MS.

Psychoneuroendocrinology. 2008 Feb;33(2):188-97.

PMID:
18079067

Supplemental Content

Support Center